Completed NA INTERVENTIONAL 2-arm NCT04662827

The Effect of Palmitylethanolamide on Central and Peripheral Sensitization After Heat-induced Hyperalgesia

Sponsor: Medical University of Graz

Conditions Central Sensitisation Neuroinflammatory Response Pain, Acute Pain, Chronic

Interventions Palmithylethanolamid placebo

Updated 6 times since 2021 Last updated: Oct 31, 2023 Started: Feb 9, 2020 Primary completion: Sep 16, 2020 Completion: Sep 16, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04662827, this NA trial focuses on Central Sensitisation and Neuroinflammatory Response and remains completed. Sponsored by Medical University of Graz, it has been updated 6 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2023 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Mar 2023 — Dec 2023 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Mar 2021 — Mar 2023 [monthly]

Recruiting NA

▶ Show 1 earlier version

Jan 2021 — Mar 2021 [monthly]

Recruiting NA

First recorded

Feb 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Graz

Data source: Medical University of Graz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Graz, Austria